Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active ShortageTier 3 — Critical

DEXTROSE INJECTION USP

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DEXTROSE INJECTION USP in Canada?

Yes. DEXTROSE INJECTION USP 500MG has an active shortage reported to Health Canada (last updated October 8, 2026).

Why is DEXTROSE INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DEXTROSE INJECTION USP be available again?

The manufacturer's estimated resolution date is November 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file1 product
Expected resolution~18 days remaining (estimate)
Affected strength500MG
Report last updated2026-10-08
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DEXTROSE INJECTION USP

ICU MEDICAL CANADA INC

50MG · DIN 00037915

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low. This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2026-11-30

~18 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02468514

Strength

500MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

DEXTROSE

Tier

Tier 3 — Critical

Last Updated

2026-10-08

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

DEXTROSE INJECTION USP has 3 shortage/discontinuation reports on file — this is one of them.